enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: 4
Filing Date: 16 Jun 2025Report Date: 16 Jun 2025
Accepted: 16 Jun 2025 08:40 p.m.
Accession Number: 0000929638-25-002252
File Number: None
Film Number: None